Fresenius Medical Care : Recovery to take even longer
>Preliminary Q3 results in line with expectations - Q3 revenues of € 5,096m (+14.7% y-o-y) were 1%/2% ahead of ODDO BHF/consensus driven primarily by forex tailwind of 11.9 percentage points, while organic growth contributed by 210bp and external growth by 70bp (both in line with our expectations). North America was again strongly impacted by labour shortage implied capacity constraints in some clinics and COVID-19 related excessive mortality that resulted in an organ...RegistrarFresenius Medical Care is a kidney dialysis company, operating in both the field of dialysis services and the field of dialysis products for the treatment of end-stage renal disease (ESRD). Co.'s dialysis business is vertically integrated, providing dialysis treatment at dialysis clinics it owns or operates and supplying these clinics with a range of products. In addition, Co. sells dialysis products to other dialysis service providers. In the U.S.A., Co. also provides inpatient dialysis services and other services under contract to hospitals. Co. provides patient services, including renal pharmaceutical products and in the U.S.A., laboratory services.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.